0001765581-20-000111.txt : 20201109
0001765581-20-000111.hdr.sgml : 20201109
20201109165345
ACCESSION NUMBER: 0001765581-20-000111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201105
FILED AS OF DATE: 20201109
DATE AS OF CHANGE: 20201109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Keefe Kenneth W
CENTRAL INDEX KEY: 0001397661
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33500
FILM NUMBER: 201298441
MAIL ADDRESS:
STREET 1: C/O BEECKEN PETTY O'KEEFE & COMPANY
STREET 2: 131 S. DEARBORN STREET, SUITE 2800
CITY: CHICAGO
STATE: IL
ZIP: 60603
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc
CENTRAL INDEX KEY: 0001232524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981032470
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 353-1-634-7800
MAIL ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030513
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-11-05
0
0001232524
Jazz Pharmaceuticals plc
JAZZ
0001397661
O'Keefe Kenneth W
5TH FL, WATERLOO EXCHANGE
WATERLOO RD
DUBLIN 4
L2
IRELAND
1
0
0
0
Ordinary Shares
2020-11-05
4
S
0
2001
152.5711
D
27666
D
Ordinary Shares
2020-11-05
4
S
0
2740
153.7428
D
24926
D
Ordinary Shares
2020-11-05
4
S
0
1746
155.1359
D
23180
D
Ordinary Shares
2020-11-05
4
S
0
4513
156.4377
D
18667
D
Ordinary Shares
4445
I
by Trust
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $152.319 to $152.83 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $153.355 to $154.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $154.91 to $155.73 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $156.00 to $156.99 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.
By: /s/Doris Choi, as attorney in fact For: Kenneth W O'Keefe
2020-11-08